Cargando…
Development and testing of the Measure of Innovation-Specific Implementation Intentions (MISII) using Rasch measurement theory
BACKGROUND: Implementation is proposed to be a multiphase, multilevel process. After a period of exploration, an adoption decision is made, typically at the upper management or policy level. Nevertheless, movement through each of the subsequent phases of the implementation process involves clinician...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6027766/ https://www.ncbi.nlm.nih.gov/pubmed/29954409 http://dx.doi.org/10.1186/s13012-018-0782-1 |
_version_ | 1783336665892257792 |
---|---|
author | Moullin, Joanna C. Ehrhart, Mark G. Aarons, Gregory A. |
author_facet | Moullin, Joanna C. Ehrhart, Mark G. Aarons, Gregory A. |
author_sort | Moullin, Joanna C. |
collection | PubMed |
description | BACKGROUND: Implementation is proposed to be a multiphase, multilevel process. After a period of exploration, an adoption decision is made, typically at the upper management or policy level. Nevertheless, movement through each of the subsequent phases of the implementation process involves clinicians or providers at the individual level to adopt the innovation and then change their behavior to use/deliver the innovation. Multiple behavioral change theories propose that intentions are a critical determinant of implementation behavior. However, there is a need for the development and testing of pragmatic measures of providers’ intentions to use a specific innovation or evidence-based practice (EBP). METHODS: Nine items were developed to assess providers’ intentions to use a specific innovation or EBP. Motivational interviewing was the EBP in the study. Items were administered, as part of larger survey, to 179 providers across 38 substance use disorder treatment (SUDT) programs within five agencies in California, USA. Rasch analysis was conducted using RUMM2030 software to assess the items, their overall fit to the Rasch model, the response scale used, individual item fit, differential item functioning (DIF), and person separation. RESULTS: Following a stepwise process, the scale was reduced from nine items to three items to increase the feasibility and acceptability of the scale while maintaining suitable psychometric properties. The three-item unidimensional scale showed good person separation (PSI = .872), no disordering of thresholds, and no evidence of uniform or non-uniform DIF. Rasch analysis supported the viability of the scale as a measure of implementation intentions. CONCLUSIONS: The Measure of Innovation-Specific Implementation Intentions (MISII) is a sound measure of providers’ intentions to use a specific innovation or EBP. Future evaluation of convergent, divergent, and predictive validity are needed. The study also demonstrates the value of Rasch analysis for testing the psychometric properties of pragmatic implementation measures. |
format | Online Article Text |
id | pubmed-6027766 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-60277662018-07-09 Development and testing of the Measure of Innovation-Specific Implementation Intentions (MISII) using Rasch measurement theory Moullin, Joanna C. Ehrhart, Mark G. Aarons, Gregory A. Implement Sci Research BACKGROUND: Implementation is proposed to be a multiphase, multilevel process. After a period of exploration, an adoption decision is made, typically at the upper management or policy level. Nevertheless, movement through each of the subsequent phases of the implementation process involves clinicians or providers at the individual level to adopt the innovation and then change their behavior to use/deliver the innovation. Multiple behavioral change theories propose that intentions are a critical determinant of implementation behavior. However, there is a need for the development and testing of pragmatic measures of providers’ intentions to use a specific innovation or evidence-based practice (EBP). METHODS: Nine items were developed to assess providers’ intentions to use a specific innovation or EBP. Motivational interviewing was the EBP in the study. Items were administered, as part of larger survey, to 179 providers across 38 substance use disorder treatment (SUDT) programs within five agencies in California, USA. Rasch analysis was conducted using RUMM2030 software to assess the items, their overall fit to the Rasch model, the response scale used, individual item fit, differential item functioning (DIF), and person separation. RESULTS: Following a stepwise process, the scale was reduced from nine items to three items to increase the feasibility and acceptability of the scale while maintaining suitable psychometric properties. The three-item unidimensional scale showed good person separation (PSI = .872), no disordering of thresholds, and no evidence of uniform or non-uniform DIF. Rasch analysis supported the viability of the scale as a measure of implementation intentions. CONCLUSIONS: The Measure of Innovation-Specific Implementation Intentions (MISII) is a sound measure of providers’ intentions to use a specific innovation or EBP. Future evaluation of convergent, divergent, and predictive validity are needed. The study also demonstrates the value of Rasch analysis for testing the psychometric properties of pragmatic implementation measures. BioMed Central 2018-06-28 /pmc/articles/PMC6027766/ /pubmed/29954409 http://dx.doi.org/10.1186/s13012-018-0782-1 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Moullin, Joanna C. Ehrhart, Mark G. Aarons, Gregory A. Development and testing of the Measure of Innovation-Specific Implementation Intentions (MISII) using Rasch measurement theory |
title | Development and testing of the Measure of Innovation-Specific Implementation Intentions (MISII) using Rasch measurement theory |
title_full | Development and testing of the Measure of Innovation-Specific Implementation Intentions (MISII) using Rasch measurement theory |
title_fullStr | Development and testing of the Measure of Innovation-Specific Implementation Intentions (MISII) using Rasch measurement theory |
title_full_unstemmed | Development and testing of the Measure of Innovation-Specific Implementation Intentions (MISII) using Rasch measurement theory |
title_short | Development and testing of the Measure of Innovation-Specific Implementation Intentions (MISII) using Rasch measurement theory |
title_sort | development and testing of the measure of innovation-specific implementation intentions (misii) using rasch measurement theory |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6027766/ https://www.ncbi.nlm.nih.gov/pubmed/29954409 http://dx.doi.org/10.1186/s13012-018-0782-1 |
work_keys_str_mv | AT moullinjoannac developmentandtestingofthemeasureofinnovationspecificimplementationintentionsmisiiusingraschmeasurementtheory AT ehrhartmarkg developmentandtestingofthemeasureofinnovationspecificimplementationintentionsmisiiusingraschmeasurementtheory AT aaronsgregorya developmentandtestingofthemeasureofinnovationspecificimplementationintentionsmisiiusingraschmeasurementtheory |